Retroperitoneoscopy-assisted total nephroureterectomy for upper urinary tract transitional cell carcinoma

Area of Science:

• Urology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Upper urinary tract transitional cell carcinoma (UT-TCC) is typically treated with standard total nephroureterectomy (STN).
• Retroperitoneoscopy-assisted nephroureterectomy (RTN) is an alternative minimally invasive approach.
• Evaluating the benefits of RTN compared to STN is crucial for optimizing treatment strategies.

Purpose of the Study:

• To assess the efficacy and safety of retroperitoneoscopy-assisted nephroureterectomy (RTN).
• To compare RTN with standard total nephroureterectomy (STN) for upper urinary tract transitional cell carcinoma.
• To analyze operative outcomes, recovery, and oncologic control.

Main Methods:

• A comparative study involving 17 patients undergoing RTN and 17 patients undergoing STN for UT-TCC.
• RTN involved retroperitoneoscopic radical nephrectomy followed by open distal ureterectomy with bladder cuff excision.
• Specimens were removed en bloc through a lower pararectal incision.

Main Results:

• RTN demonstrated significantly reduced estimated blood loss, shorter hospital stays, and faster return to normal activities compared to STN.
• Operative time was slightly longer in the RTN group but not statistically significant.
• Local recurrence rates were lower in the RTN group (1/17) than in the STN group (4/17), with comparable disease-free survival rates.

Conclusions:

• Retroperitoneoscopy-assisted nephroureterectomy (RTN) offers a less invasive surgical option for upper urinary tract transitional cell carcinoma.
• RTN provides comparable oncologic outcomes to standard open nephroureterectomy (STN) in the short term.
• Further long-term follow-up and studies incorporating lymphadenectomy are needed to fully establish RTN's effectiveness.